Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $BLTE vs $CORT | Chartloom

Compare

$BLTE vs $CORT

Belite Bio Inc · Corcept Therapeutics Inc

BLTE

Belite Bio Inc

CORT

Corcept Therapeutics Inc

Compare $BLTE vs $CORT

Comparing Belite Bio Inc and Corcept Therapeutics Inc

BLTEBelite Bio Inc

CORTCorcept Therapeutics Inc

BLTEBelite Bio Inc

Market cap

$5.70B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

21.92x

Rev growth (TTM)

—

YTD performance

-4.6%

52W performance

91.6%

FCF yield

0.0%

CORTCorcept Therapeutics Inc

Market cap

$12.73B

P/E (TTM)

252.72x

Forward P/E (NTM)

28.94x

Forward P/S (NTM)

8.27x

Rev growth (TTM)

16.0%

YTD performance

208.4%

52W performance

59.3%

FCF yield

0.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BLTE

CORT

Detailed metrics comparison

BLTE

Belite Bio Inc

CORT

Corcept Therapeutics Inc

Market Cap

BLTE$5.70B

CORT$12.73B

Enterprise Value

BLTE$5.70B

CORT$12.62B

Price

BLTE$151.87

CORT$117.80

P/E Ratio

BLTEN/A

CORT252.72x

P/S Ratio

BLTE0.00x

CORT15.33x

EV/Sales

BLTE0.00x

CORT15.19x

EV/EBITDA

BLTE0.00x

CORT1,442.80x

P/B Ratio

BLTE7.97x

CORT18.56x

P/FCF Ratio

BLTEN/A

CORT119.10x

EV/FCF

BLTE0.00x

CORT118.06x

PEG Ratio

BLTEN/A

CORTN/A

Forward P/E (NTM)

BLTEN/A

CORT28.94x

Forward P/S (NTM)

BLTE21.92x

CORT8.27x

Revenue (TTM)

BLTE$0

CORT$831M

Revenue Growth (YoY)

BLTEN/A

CORT16.0%

Forward Rev Growth

BLTE97.1%

CORT48.8%

Gross Margin (TTM)

BLTE0.0%

CORT98.3%

Operating Margin (TTM)

BLTE0.0%

CORT0.8%

EBITDA Margin (TTM)

BLTE0.0%

CORT1.0%

Net Margin (TTM)

BLTE0.0%

CORT6.6%

FCF Margin (TTM)

BLTEN/A

CORT12.9%

Net Income (TTM)

BLTE$-116M

CORT$55M

FCF (TTM)

BLTE$0

CORT$107M

EPS (TTM)

BLTE-$3.07

CORT$0.47

ROE (TTM)

BLTE-2687.0%

CORT8.4%

ROA (TTM)

BLTE-2626.0%

CORT6.6%

ROIC (TTM)

BLTE-2687.0%

CORT8.4%

Cash

BLTE$0

CORT$111M

Debt

BLTE$0

CORT$0

Net Cash/Debt

BLTE$0

CORT$111M

Current Ratio (TTM)

BLTE50.02x

CORT2.86x

Quick Ratio (TTM)

BLTE49.90x

CORT2.63x

Debt/Equity (TTM)

BLTE0.00x

CORT0.00x

Debt/Assets (TTM)

BLTE0.0%

CORT0.0%

Interest Coverage (TTM)

BLTEN/A

CORTN/A

Net Debt/EBITDA (TTM)

BLTE0.00x

CORT0.00x

Beta

BLTE-1.22

CORT0.52

52W Performance

BLTE91.6%

CORT59.3%

YTD Performance

BLTE-4.6%

CORT208.4%

% from 52W High

BLTE-24.1%

CORT-6.8%

% from 52W Low

BLTE92.9%

CORT311.0%

Asset Turnover (TTM)

BLTE0.00x

CORT0.99x

FCF Yield (TTM)

BLTE0.0%

CORT0.8%

Earnings Yield (TTM)

BLTE-2.0%

CORT0.4%

Dividend Yield (TTM)

BLTEN/A

CORTN/A

Rule of 40

BLTE0.0

CORT28.9

EV/GP/RG

BLTEN/A

CORT0.18

Ticker research

View BLTE research View CORT research

Metric	BLTE Belite Bio Inc	CORT Corcept Therapeutics Inc
Market & Valuation
Market Cap	$5.70B	$12.73B
Enterprise Value	$5.70B	$12.62B
Price	$151.87	$117.80
P/E Ratio	N/A	252.72x
P/S Ratio	0.00x	15.33x
EV/Sales	0.00x	15.19x
EV/EBITDA	0.00x	1,442.80x
P/B Ratio	7.97x	18.56x
P/FCF Ratio	N/A	119.10x
EV/FCF	0.00x	118.06x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	28.94x
Forward P/S (NTM)	21.92x	8.27x
Revenue & Growth
Revenue (TTM)	$0	$831M
Revenue Growth (YoY)	N/A	16.0%
Forward Rev Growth	97.1%	48.8%
Profitability
Gross Margin (TTM)	0.0%	98.3%
Operating Margin (TTM)	0.0%	0.8%
EBITDA Margin (TTM)	0.0%	1.0%
Net Margin (TTM)	0.0%	6.6%
FCF Margin (TTM)	N/A	12.9%
Net Income (TTM)	$-116M	$55M
FCF (TTM)	$0	$107M
EPS (TTM)	-$3.07	$0.47
ROE (TTM)	-2687.0%	8.4%
ROA (TTM)	-2626.0%	6.6%
ROIC (TTM)	-2687.0%	8.4%
Financial Health
Cash	$0	$111M
Debt	$0	$0
Net Cash/Debt	$0	$111M
Current Ratio (TTM)	50.02x	2.86x
Quick Ratio (TTM)	49.90x	2.63x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-1.22	0.52
52W Performance	91.6%	59.3%
YTD Performance	-4.6%	208.4%
% from 52W High	-24.1%	-6.8%
% from 52W Low	92.9%	311.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.99x
FCF Yield (TTM)	0.0%	0.8%
Earnings Yield (TTM)	-2.0%	0.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	28.9
EV/GP/RG	N/A	0.18
Ticker research	View BLTE research	View CORT research

Valuation

P/E Ratio

CORT

252.72x

P/S Ratio

BLTE

0.00x

CORT

15.33x

EV/FCF

BLTE

0.00x

CORT

118.06x

Growth & revenue

Revenue Growth TTM

CORT

16.0%

Forward Revenue Growth

BLTE

97.1%

CORT

48.8%

Profitability & performance

Gross Margin

CORT

98.3%

BLTE

0.0%

ROE

CORT

8.4%

BLTE

-2687.0%

FCF Yield %

CORT

0.8%

BLTE

0.0%

52-Week Performance

BLTE

91.6%

CORT

59.3%

Detailed metrics comparison

BLTE

Belite Bio Inc

CORT

Corcept Therapeutics Inc

Market Cap

BLTE$5.70B

CORT$12.73B

Enterprise Value

BLTE$5.70B

CORT$12.62B

Price

BLTE$151.87

CORT$117.80

P/E Ratio

BLTEN/A

CORT252.72x

P/S Ratio

BLTE0.00x

CORT15.33x

EV/Sales

BLTE0.00x

CORT15.19x

EV/EBITDA

BLTE0.00x

CORT1,442.80x

P/B Ratio

BLTE7.97x

CORT18.56x

P/FCF Ratio

BLTEN/A

CORT119.10x

EV/FCF

BLTE0.00x

CORT118.06x

PEG Ratio

BLTEN/A

CORTN/A

Forward P/E (NTM)

BLTEN/A

CORT28.94x

Forward P/S (NTM)

BLTE21.92x

CORT8.27x

Revenue (TTM)

BLTE$0

CORT$831M

Revenue Growth (YoY)

BLTEN/A

CORT16.0%

Forward Rev Growth

BLTE97.1%

CORT48.8%

Gross Margin (TTM)

BLTE0.0%

CORT98.3%

Operating Margin (TTM)

BLTE0.0%

CORT0.8%

EBITDA Margin (TTM)

BLTE0.0%

CORT1.0%

Net Margin (TTM)

BLTE0.0%

CORT6.6%

FCF Margin (TTM)

BLTEN/A

CORT12.9%

Net Income (TTM)

BLTE$-116M

CORT$55M

FCF (TTM)

BLTE$0

CORT$107M

EPS (TTM)

BLTE-$3.07

CORT$0.47

ROE (TTM)

BLTE-2687.0%

CORT8.4%

ROA (TTM)

BLTE-2626.0%

CORT6.6%

ROIC (TTM)

BLTE-2687.0%

CORT8.4%

Cash

BLTE$0

CORT$111M

Debt

BLTE$0

CORT$0

Net Cash/Debt

BLTE$0

CORT$111M

Current Ratio (TTM)

BLTE50.02x

CORT2.86x

Quick Ratio (TTM)

BLTE49.90x

CORT2.63x

Debt/Equity (TTM)

BLTE0.00x

CORT0.00x

Debt/Assets (TTM)

BLTE0.0%

CORT0.0%

Interest Coverage (TTM)

BLTEN/A

CORTN/A

Net Debt/EBITDA (TTM)

BLTE0.00x

CORT0.00x

Beta

BLTE-1.22

CORT0.52

52W Performance

BLTE91.6%

CORT59.3%

YTD Performance

BLTE-4.6%

CORT208.4%

% from 52W High

BLTE-24.1%

CORT-6.8%

% from 52W Low

BLTE92.9%

CORT311.0%

Asset Turnover (TTM)

BLTE0.00x

CORT0.99x

FCF Yield (TTM)

BLTE0.0%

CORT0.8%

Earnings Yield (TTM)

BLTE-2.0%

CORT0.4%

Dividend Yield (TTM)

BLTEN/A

CORTN/A

Rule of 40

BLTE0.0

CORT28.9

EV/GP/RG

BLTEN/A

CORT0.18

Ticker research

View BLTE research View CORT research

Metric	BLTE Belite Bio Inc	CORT Corcept Therapeutics Inc
Market & Valuation
Market Cap	$5.70B	$12.73B
Enterprise Value	$5.70B	$12.62B
Price	$151.87	$117.80
P/E Ratio	N/A	252.72x
P/S Ratio	0.00x	15.33x
EV/Sales	0.00x	15.19x
EV/EBITDA	0.00x	1,442.80x
P/B Ratio	7.97x	18.56x
P/FCF Ratio	N/A	119.10x
EV/FCF	0.00x	118.06x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	28.94x
Forward P/S (NTM)	21.92x	8.27x
Revenue & Growth
Revenue (TTM)	$0	$831M
Revenue Growth (YoY)	N/A	16.0%
Forward Rev Growth	97.1%	48.8%
Profitability
Gross Margin (TTM)	0.0%	98.3%
Operating Margin (TTM)	0.0%	0.8%
EBITDA Margin (TTM)	0.0%	1.0%
Net Margin (TTM)	0.0%	6.6%
FCF Margin (TTM)	N/A	12.9%
Net Income (TTM)	$-116M	$55M
FCF (TTM)	$0	$107M
EPS (TTM)	-$3.07	$0.47
ROE (TTM)	-2687.0%	8.4%
ROA (TTM)	-2626.0%	6.6%
ROIC (TTM)	-2687.0%	8.4%
Financial Health
Cash	$0	$111M
Debt	$0	$0
Net Cash/Debt	$0	$111M
Current Ratio (TTM)	50.02x	2.86x
Quick Ratio (TTM)	49.90x	2.63x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-1.22	0.52
52W Performance	91.6%	59.3%
YTD Performance	-4.6%	208.4%
% from 52W High	-24.1%	-6.8%
% from 52W Low	92.9%	311.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.99x
FCF Yield (TTM)	0.0%	0.8%
Earnings Yield (TTM)	-2.0%	0.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	28.9
EV/GP/RG	N/A	0.18
Ticker research	View BLTE research	View CORT research